Mixed Results With Leukemia Drug in Parkinson’s
The authors say low doses of nilotinib were ‘reasonably safe’ in this phase 2 trial, an assessment questioned by authors of an accompanying editorial.
Related Articles
Home
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Friday, December 6, 2024 3:30 pm – 5:00 pm PT Room: Grand Ballroom 8-9 Marriott Marquis SD | San Diego, California CME/CNE/CPE Hybrid Join a…
Home
Sunday, 15 September, 2024 | 13:00 – 14:30 CEST BURGOS AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
Home
Monday, 16 September, 2024 | 18:30 – 20:00 CEST VALENCIA AUDITORIUM, HALL 5, FIRA BARCELONA GRAN VIA, BARCELONA, SPAIN Supported by an independent educational grant…
MDT Care in Endometrial Cancer: Responsibilities of the Care Team
Join Medscape Oncology for a live interactive social media event on themultidisciplinary care for patients with endometrial cancer. Our multidisciplinarypane…